All The Microbiologist articles in Vaccines and Phage
View all stories from this issue.
-
FeaturesA double-tap strategy for dislodging superbugs: combined use of phage and probiotics
How we can use a combined approach to therapy to overcome the challenges associated with each part of the whole.
-
CareersPhage against the dying of the light - bacteriophages have been sparking a buzz for over a century now
Tom Ireland’s latest book The Good Virus reveals the rollercoaster history of bacteriophages - and why these prolific entities could offer fresh hope in a time of surging antimicrobial resistance.
-
NewsNew VDEC is ‘step change’ for UK’s growing vaccine capabilities
The UK Health Security Agency has unveiled its world-leading Vaccine Development and Evaluation Centre at Porton Down, which will be at the forefront of the UK’s ability to develop vaccines against the world’s deadliest pathogens.
-
NewsParasites of viruses drive superbug evolution
Researchers have discovered a previously unknown mechanism by which bacteria share their genetic material through virus parasites.
-
FeaturesAntimicrobial resistance and phage therapy in India
The story that led to the formation of Vitalis Phage Therapy - the first of its kind initiative to establish frameworks for phage therapy in India.
-
OpinionNew RSV vaccines on the way - so what do we do about vaccine hesitancy?
Not one, but two promising new vaccines are likely to be introduced to the UK, yet routine childhood vaccination rates have been decreasing for ‘old’ diseases like measles and polio - what’s going on?
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
OpinionDoes the world need another antibiotic?
Barriers, opportunities and alternatives in the fight against AMR.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
NewsNewly discovered antibodies can neutralize COVID-19 variants
Scientists have isolated potent neutralizing antibodies from a COVID-19 vaccinated SARS survivor that exhibited remarkable breadth against known sarbecoviruses.
-
NewsThe Phage-Microbiome Consortium is launched
The International Society of Microbiota (ISM) has announced the launch of a new initiative: The Phage-Microbiome Consortium.
-
NewsEavesdropping viruses wait for bacterial signals before switching to kill mode
Researchers have found that dozens of viruses respond to quorum sensing or other chemical signals from bacteria.
-
NewsSpike protein mutants with low binding affinity usher in new Covid vaccine
Researchers have succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
-
NewsRapid test for cystitis deploys phages to destroy pathogens
Scientists have developed a rapid test that employs the natural viral predators of bacteria, bacteriophages. The researchers also genetically modified the phages to make them more efficient at destroying the pathogenic bacteria.
-
-
NewsBreakthrough harnesses mRNA technology to develop malaria vaccine
A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year, yet has no effective long-lasting vaccine.
-
NewsNew MenB vaccine heralds use of genetic vaccines to combat bacterial diseases
A vaccine candidate that can protect children from Meningococcal group B (MenB), which can lead to meningitis, has progressed to clinical development, researchers say.
-
NewsPartnership to use AI to speed up vaccine development against Disease X
CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats.
-
NewsNew cholera substrains in Bangladesh uncovered by genomic surveillance
Researchers have uncovered two new cholera substrains in a displaced refugee population in southern Bangladesh, where a pre-emptive mass vaccination campaign of over one million refugees was successful in preventing an epidemic.
-
NewsFiji launches mass vaccination campaign against typhoid
The Ministry of Health and Medical Services (MHMS) of Fiji has launched a mass vaccination campaign against typhoid in the Northern Division, aiming to immunize the entire population between 9 months and 65 years of age.
